An investigation for investors in Cellceutix Corp (OTCMKTS:CTIX) shares over potential securities laws violations by Cellceutix was announced and OTCMKTS:CTIX stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 08/26/2015 --An investigation on behalf of investors of Cellceutix Corp (OTCMKTS:CTIX) shares over potential securities laws violations by Cellceutix and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Cellceutix Corp (OTCMKTS:CTIX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Cellceutix Corp (OTCMKTS:CTIX) concerning whether a series of statements by Cellceutix Corp regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 6, 2015, an article was published revealing that Cellceutix Corp (OTCMKTS:CTIX) misrepresented the efficacy of its drug candidates Brilacidin, Kevetrin, and Prurisol. Shares of Cellceutix Corp OTCMKTS:CTIX) declined on August 7, 2015, to as low as $1.32 per share.

Those who purchased shares of Cellceutix Corp (OTCMKTS:CTIX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com